Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1539 Views
-
Last post by goellerc
-
- 0 Replies
- 1073 Views
-
Last post by ElliotB
-
- 0 Replies
- 1141 Views
-
Last post by Petr75
-
- 61 Replies
- 12540 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4818 Views
-
Last post by NHE
-
- 0 Replies
- 1340 Views
-
Last post by NHE
-
- 5 Replies
- 11813 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1428 Views
-
Last post by ElliotB
-
- 0 Replies
- 490 Views
-
Last post by DIM